Steroid hormone receptor coactivation and alternative RNA splicing by U2AF65-related proteins CAPERα and CAPERβ

Molecular Cell

Volumn 17, Issue 3, 2005, Pages 429-439

  Dowhan, Dennis H ^a   Hong, Eugene P ^a   Auboeuf, Didier ^a   Dennis, Andrew P ^a   Wilson, Michelle M ^a   Berget, Susan M ^a   O'Malley, Bert W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CAPER ALPHA PROTEIN; CAPER BETA PROTEIN; LUCIFERASE; PROGESTERONE RECEPTOR; RNA BINDING PROTEIN; SMALL INTERFERING RNA; STEROID RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KNOCKOUT GENE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CALCITONIN GENE-RELATED PEPTIDE; CELL LINE; CERCOPITHECUS AETHIOPS; ESTROGEN RECEPTOR ALPHA; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; RECEPTORS, PROGESTERONE; RECEPTORS, STEROID; RECOMBINANT FUSION PROTEINS; RIBONUCLEOPROTEINS; RNA PRECURSORS; RNA, SMALL INTERFERING; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

CAPPARIS SPINOSA;

EID: 13244253805     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2004.12.025     Document Type: Article

References (49)

1. Amara S.G., Jonas V., Rosenfeld M.G., Ong E.S., Evans R.M. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature. 298:1982;240-244
2. Auboeuf D., Honig A., Berget S.M., O'Malley B.W. Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science. 298:2002;416-419
3. Auboeuf D., Dowhan D.H., Li X., Larkin K., Ko L., Berget S.M., O'Malley B.W. CoAA, a nuclear receptor coactivator protein at the interface of transcriptional coactivation and RNA splicing. Mol. Cell. Biol. 24:2004;442-453
4. Birney E., Kumar S., Krainer A.R. Analysis of the RNA-recognition motif and RS and RGG domains. conservation in metazoan pre-mRNA splicing factors Nucleic Acids Res. 21:1993;5803-5816
5. Chen S.L., Dowhan D.H., Hosking B.M., Muscat G.E. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. Genes Dev. 14:2000;1209-1228
6. Cramer P., Pesce C.G., Baralle F.E., Kornblihtt A.R. Functional association between promoter structure and transcript alternative splicing. Proc. Natl. Acad. Sci. USA. 94:1997;11456-11460
7. Cramer P., Caceres J.F., Cazalla D., Kadener S., Muro A.F., Baralle F.E., Kornblihtt A.R. Coupling of transcription with alternative splicing. RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer Mol. Cell. 4:1999;251-258
8. Cramer P., Srebrow A., Kadener S., Werbajh S., de la Mata M., Melen G., Nogues G., Kornblihtt A.R. Coordination between transcription and pre-mRNA processing. FEBS Lett. 498:2001;179-182
9. Davies R.C., Calvio C., Bratt E., Larsson S.H., Lamond A.I., Hastie N.D. WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes. Genes Dev. 12:1998;3217-3225
10. de la Mata M., Alonso C.R., Kadener S., Fededa J.P., Blaustein M., Pelisch F., Cramer P., Bentley D., Kornblihtt A.R. A slow RNA polymerase II affects alternative splicing in vivo. Mol. Cell. 12:2003;525-532
11. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498
12. Ge H., Si Y., Wolffe A.P. A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2. Mol. Cell. 2:1998;751-759
13. Goldstrohm A.C., Greenleaf A.L., Garcia-Blanco M.A. Co-transcriptional splicing of pre-messenger RNAs. considerations for the mechanism of alternative splicing Gene. 277:2001;31-47
14. Hallier M., Tavitian A., Moreau-Gachelin F. The transcription factor Spi-1/PU.1 binds RNA and interferes with the RNA-binding protein p54nrb. J. Biol. Chem. 271:1996;11177-11181
15. Hallier M., Lerga A., Barnache S., Tavitian A., Moreau-Gachelin F. The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS. J. Biol. Chem. 273:1998;4838-4842
16. Hyder S.M., Murthy L., Stancel G.M. Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer Res. 58:1998;392-395
17. Hyder S.M., Chiappetta C., Stancel G.M. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells. Int. J. Cancer. 92:2001;469-473
18. Imai H., Chan E.K., Kiyosawa K., Fu X.D., Tan E.M. Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma. J. Clin. Invest. 92:1993;2419-2426
19. Jung D.J., Na S.Y., Na D.S., Lee J.W. Molecular cloning and characterization of CAPER, a novel coactivator of activating protein-1 and estrogen receptors. J. Biol. Chem. 277:2002;1229-1234
20. Kadener S., Cramer P., Nogues G., Cazalla D., de la Mata M., Fededa J.P., Werbajh S.E., Srebrow A., Kornblihtt A.R. Antagonistic effects of T-Ag and VP16 reveal a role for RNA pol II elongation on alternative splicing. EMBO J. 20:2001;5759-5768
21. Kadener S., Fededa J.P., Rosbash M., Kornblihtt A.R. Regulation of alternative splicing by a transcriptional enhancer through RNA pol II elongation. Proc. Natl. Acad. Sci. USA. 99:2002;8185-8190
22. Kenan D.J., Query C.C., Keene J.D. RNA recognition. towards identifying determinants of specificity Trends Biochem. Sci. 16:1991;214-220
23. Lai M.C., Teh B.H., Tarn W.Y. A human papillomavirus E2 transcriptional activator. The interactions with cellular splicing factors and potential function in pre-mRNA processing. J. Biol. Chem. 274:1999;11832-11841
24. Lennon G., Auffray C., Polymeropoulos M., Soares M.B. The I.M.A.G.E. Consortium. an integrated molecular analysis of genomes and their expression Genomics. 33:1996;151-152
25. Li X., Wong J., Tsai S.Y., Tsai M.-J., O'Malley B.W. Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol. Cell. Biol. 23:2003;3763-3773
26. Lou H., Gagel R.F. Alternative ribonucleic acid processing in endocrine systems. Endocr. Rev. 22:2001;205-225
27. Lou H., Helfman D.M., Gagel R.F., Berget S.M. Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3′-terminal exon. Mol. Cell. Biol. 19:1999;78-85
28. Maniatis T., Reed R. An extensive network of coupling among gene expression machines. Nature. 416:2002;499-506
29. McNeil G.P., Schroeder A.J., Roberts M.A., Jackson F.R. Genetic analysis of functional domains within the Drosophila LARK RNA-binding protein. Genetics. 159:2001;229-240
30. Monsalve M., Wu Z., Adelmant G., Puigserver P., Fan M., Spiegelman B.M. Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. Mol. Cell. 6:2000;307-316
31. Nogues G., Kadener S., Cramer P., Bentley D., Kornblihtt A.R. Transcriptional activators differ in their abilities to control alternative splicing. J. Biol. Chem. 277:2002;43110-43114
32. Nogues G., Munoz M.J., Kornblihtt A.R. Influence of Polymerase II processivity on alternative splicing depends on splice site strength. J. Biol. Chem. 278:2003;52166-52171
33. Oubridge C., Ito N., Evans P.R., Teo C.H., Nagai K. Crystal structure at 1.92 Å resolution of the RNA-binding domain of the U1A spliceosomal protein complexed with an RNA hairpin. Nature. 372:1994;432-438
34. Pagani F., Stuani C., Zuccato E., Kornblihtt A.R., Baralle F.E. Promoter architecture modulates CFTR exon 9 skipping. J. Biol. Chem. 278:2003;1511-1517
35. Page-McCaw P.S., Amonlirdviman K., Sharp P.A. PUF60. a novel U2AF65-related splicing activity RNA. 5:1999;1548-1560
36. Rappsilber J., Ryder U., Lamond A.I., Mann M. Large-scale proteomic analysis of the human spliceosome. Genome Res. 12:2002;1231-1245
37. Ren L., Marquardt M.A., Lech J.J. Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7. Chem. Biol. Interact. 104:1997;55-64
38. Roscigno R.F., Weiner M., Garcia-Blanco M.A. A mutational analysis of the polypyrimidine tract of introns. Effects of sequence differences in pyrimidine tracts on splicing. J. Biol. Chem. 268:1993;11222-11229
39. Rosenfeld M.G., Amara S.G., Evans R.M. Alternative RNA processing. determining neuronal phenotype Science. 225:1984;1315-1320
40. Rosonina E., Bakowski M.A., McCracken S., Blencowe B.J. Transcriptional activators control splicing and 3′-end cleavage levels. J. Biol. Chem. 278:2003;43034-43040
41. Ruskin B., Zamore P.D., Green M.R. A factor, U2AF, is required for U2 snRNP binding and splicing complex assembly. Cell. 52:1988;207-219
42. Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., Altschul S.F., et al. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA. 99:2002;16899-16903
43. Tacke R., Manley J.L. Determinants of SR protein specificity. Curr. Opin. Cell Biol. 11:1999;358-362
44. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J.C., Abraham J.A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266:1991;11947-11954
45. Van Buskirk C., Schupbach T. Half pint regulates alternative splice site selection in Drosophila. Dev. Cell. 2:2002;343-353
46. Wellmann S., Taube T., Paal K., Graf V.E.H., Geilen W., Seifert G., Eckert C., Henze G., Seeger K. Specific reverse transcription-PCR quantification of vascular endothelial growth factor (VEGF) splice variants by LightCycler technology. Clin. Chem. 47:2001;654-660
47. Zamore P.D., Green M.R. Identification, purification, and biochemical characterization of U2 small nuclear ribonucleoprotein auxiliary factor. Proc. Natl. Acad. Sci. USA. 86:1989;9243-9247
48. Zamore P.D., Patton J.G., Green M.R. Cloning and domain structure of the mammalian splicing factor U2AF. Nature. 355:1992;609-614
49. Zuo P., Maniatis T. The splicing factor U2AF35 mediates critical protein-protein interactions in constitutive and enhancer-dependent splicing. Genes Dev. 10:1996;1356-1368